- Home
- ATNF vs PRSO Comparison
ATNF vs PRSO Comparison
Compare ATNF & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- PRSO
- Stock Information
- Founded
- ATNF 2016
- PRSO 2008
- Country
- ATNF United States
- PRSO United States
- Employees
- ATNF N/A
- PRSO N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- ATNF Health Care
- PRSO Technology
- Exchange
- ATNF Nasdaq
- PRSO Nasdaq
- Market Cap
- ATNF 4.1M
- PRSO 3.3M
- IPO Year
- ATNF N/A
- PRSO 2001
- Fundamental
- Price
- ATNF $1.25
- PRSO $0.94
- Analyst Decision
- ATNF
- PRSO Strong Buy
- Analyst Count
- ATNF 0
- PRSO 2
- Target Price
- ATNF N/A
- PRSO $3.38
- AVG Volume (30 Days)
- ATNF 84.0K
- PRSO 76.9K
- Earning Date
- ATNF 03-04-2025
- PRSO 03-17-2025
- Dividend Yield
- ATNF N/A
- PRSO N/A
- EPS Growth
- ATNF N/A
- PRSO N/A
- EPS
- ATNF N/A
- PRSO N/A
- Revenue
- ATNF N/A
- PRSO $12,728,000.00
- Revenue This Year
- ATNF N/A
- PRSO $9.59
- Revenue Next Year
- ATNF $54.15
- PRSO $1.63
- P/E Ratio
- ATNF N/A
- PRSO N/A
- Revenue Growth
- ATNF N/A
- PRSO N/A
- 52 Week Low
- ATNF $1.16
- PRSO $0.73
- 52 Week High
- ATNF $17.75
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- ATNF 33.17
- PRSO 50.19
- Support Level
- ATNF $1.31
- PRSO $0.82
- Resistance Level
- ATNF $1.38
- PRSO $0.92
- Average True Range (ATR)
- ATNF 0.06
- PRSO 0.07
- MACD
- ATNF 0.01
- PRSO 0.02
- Stochastic Oscillator
- ATNF 0.00
- PRSO 60.38
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.